Bat Alphacoronavirus Uses Previously Unknown Human Receptor, Raising Spillover Concerns
A recent study published in Nature reveals that a bat alphacoronavirus can enter human cells using a previously unknown receptor called CEACAM6. This finding highlights a potential new pathway for viral spillover from bats to humans, raising concerns about pandemic risks. The discovery underscores the need for enhanced surveillance and research into bat coronaviruses to bolster global health security.
Why this is uncovered
Nature News published findings on a bat alphacoronavirus using a previously unknown receptor (CEACAM6) to enter human cells, raising concerns about spillover risk and pandemic potential. This is of critical public interest for global health security and pandemic preparedness, but it is not covered in mainstream media reports.
This article was generated automatically from primary sources and has not been reviewed by a human editor. Verify claims before sharing.
Bat Alphacoronavirus Uses Previously Unknown Human Receptor, Raising Spillover Concerns
A groundbreaking study published in Nature has identified a new mechanism by which a bat alphacoronavirus can infect human cells, utilizing a receptor previously not associated with such infections. The receptor, known as CEACAM6 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6), serves as an entry point for the virus, marking a significant discovery in understanding how bat coronaviruses might cross species barriers and pose risks to human populations Nature News.
Bat coronaviruses are a well-known source of zoonotic diseases, with past outbreaks like SARS and potentially COVID-19 linked to these viruses jumping from bats to humans, often through intermediate hosts. The identification of CEACAM6 as a novel receptor for a bat alphacoronavirus adds a new dimension to this threat. According to the Nature report, this receptor provides a direct gateway for the virus to enter human cells, a pathway that was previously undocumented in scientific literature. This finding suggests that the diversity of receptors used by coronaviruses may be broader than previously thought, increasing the potential for spillover events where viruses adapt to infect humans Nature News.
The implications of this discovery are significant for global health security. Spillover events are a primary concern for pandemic preparedness, as they represent the initial step in the emergence of new infectious diseases. The use of CEACAM6 by a bat alphacoronavirus indicates that current models of viral transmission and receptor interaction may need to be updated to account for this new pathway. Researchers emphasize that understanding these mechanisms is critical for developing strategies to prevent future outbreaks. Enhanced surveillance of bat populations and their viral loads, alongside studies of human receptor diversity, could help identify and mitigate risks before they escalate into public health crises Nature News.
While the study does not confirm that this specific alphacoronavirus has caused human infections, the potential for such an event remains a concern. Bats are natural reservoirs for a wide range of coronaviruses, many of which have yet to be fully characterized. The discovery of CEACAM6 as a receptor highlights the need for continued research into the vast array of viruses harbored by bats and the mechanisms they use to interact with human cells. This knowledge is essential for creating targeted interventions, such as vaccines or antiviral therapies, that could block these entry points and prevent future pandemics Nature News.
The study also serves as a reminder of the interconnectedness of human, animal, and environmental health. As human encroachment into natural habitats increases, so does the likelihood of contact with wildlife reservoirs of potential pathogens. The identification of a new receptor for bat coronaviruses underscores the urgency of addressing these interactions through policies and practices that reduce spillover risks, such as protecting bat habitats and regulating wildlife trade Nature News.
Why this is uncovered
This critical finding about a bat alphacoronavirus using CEACAM6 as a receptor has not been widely reported in mainstream media, likely due to the complexity and specificity of the scientific content, which may not align with broader public narratives or immediate news cycles. Despite its clear public interest—given the potential implications for pandemic preparedness and global health security—it remains overshadowed by more sensational or accessible health stories. The absence of coverage represents a missed opportunity to inform the public and policymakers about emerging zoonotic risks that require urgent attention and resources.
Sources
More in Health
The European Centre for Disease Prevention and Control (ECDC) has issued a warning about an early start to the flu season in Europe, predicting a 'more severe' wave than usual. The agency is calling for immediate vaccination to mitigate the impact on public health. This alert highlights the urgency of preparedness amidst growing health concerns.
20 Apr 2026
A 15-year study in Uganda, published in JAMA and presented at a European congress, reveals that severe malaria, particularly cerebral malaria and severe anemia, causes lasting brain damage in children, leading to lower cognitive and math scores over a decade later. Affecting over 1 million children annually, this 'cognitive hit' poses a significant challenge for communities in malaria-endemic regions. Experts emphasize the global importance of preventing these long-term effects.
18 Apr 2026
A recent article in The Lancet explores the role of MEK inhibitors in treating BRAF-driven cancers, noting their limited clinical impact due to toxicity, resistance, and modest durability as a monotherapy. The study highlights severe adverse effects and the emerging importance of predictive biomarkers for patient selection and monitoring. This critical therapeutic challenge remains underreported in mainstream media despite its significance for cancer treatment advancements.
18 Apr 2026